These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Characteristic clinical features of NSAID ulcer]. Mori Y; Sasaki M; Kataoka H; Kamiya T; Joh T Nihon Rinsho; 2007 Oct; 65(10):1788-91. PubMed ID: 17926525 [TBL] [Abstract][Full Text] [Related]
27. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey. Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405 [TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal bleeding associated with the use of non-steroidal, anti-inflammatory drugs--symptomatology and clinical course. Aabakken L; Weberg R; Lygren I; Eidsvoll B; Stray N; Osnes M Agents Actions; 1992; Spec No():C86-7. PubMed ID: 1442342 [TBL] [Abstract][Full Text] [Related]
29. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs]. Lanas A; Arroyo MT Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808 [TBL] [Abstract][Full Text] [Related]
31. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558 [TBL] [Abstract][Full Text] [Related]
32. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. al-Assi MT; Genta RM; Karttunen TJ; Graham DY Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738 [TBL] [Abstract][Full Text] [Related]
33. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
34. [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs]. Bar-Dayan Y; Levi Y Harefuah; 1996 Apr; 130(8):535-7. PubMed ID: 8765878 [No Abstract] [Full Text] [Related]
35. [Current issues of NSAID-induced gastrointestinal ulcer in Japan]. Sugano K Nihon Rinsho; 2007 Oct; 65(10):1754-8. PubMed ID: 17926520 [TBL] [Abstract][Full Text] [Related]
36. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110 [TBL] [Abstract][Full Text] [Related]
38. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients. Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883 [TBL] [Abstract][Full Text] [Related]
39. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422 [TBL] [Abstract][Full Text] [Related]
40. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Hippisley-Cox J; Coupland C; Logan R BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]